Implementation of WHO Standards for Improving Maternal and Newborn Care
NCT ID: NCT06012591
Last Updated: 2024-06-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
9000 participants
INTERVENTIONAL
2022-09-01
2026-01-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In 2016, the World Health Organization (WHO) developed a framework and a list of Standards for improving the quality of maternal and newborn care (QMNC). The WHO Standards define a set of 318 Quality Measures, divided into three key domains - experience of care, provision of care and availability of resources - which can be used to assess the QMNC at facility level. The ongoing project, named IMAgiNE (Improving MAternal Newborn carE), includes all maternities hospitals of the FVG Region and aimed at improving the quality of maternal and neonatal health care in the region. Quality of care is assessed using two complementary perspectives (women and health workers), with two validated questionnaires including about 100 quality measures based on the WHO Standards. It provides data on both the baseline assessment and the Quality Improvement component (progresses made).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Maternal & Newborn Health Simulation Lab Centers of Excellence in Nepal
NCT06577922
Improving Perinatal Outcomes Using Conditional and Targeted Transfers
NCT04090762
Improving MAternal Newborn carE In the in the WHO European Region During COVID-19 Pandemic
NCT04847336
Accelerating Newborn Survival in Ghana Through a Low-dose, High-frequency Health Worker Training Approach
NCT03290924
Self-assessment Tool for Implementing the ESCNH
NCT06379828
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
WHO Standard implementation
Quality improvement recommendations (action plans)
Developed and implemented at facility level to address key quality gaps emerging from the baseline assessment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quality improvement recommendations (action plans)
Developed and implemented at facility level to address key quality gaps emerging from the baseline assessment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1\. Women who give birth at the nine maternity hospitals of the Friuli Venezia Giulia (FVG) Region, Italy
For health workers
1\. All health workers directly involved in maternal/neonatal care at facility level in the FVG Region (i.e. general physicians currently working in maternal or neonatal care, midwives, nurses, neonatologists, obstetrics and gynecology doctors, and medical residents )
Exclusion Criteria
1. Age \<18 years;
2. Stillbirth or neonatal death;
3. Psychiatric problems who may interfere with the telephone interview;
4. Hidden pregnancy or women whose child has been adopted or placed in foster care;
5. Refusal to participate.
For health workers
1. Refusal to participate;
2. Prolonged absence with unavailability during the study period.
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IRCCS Burlo Garofolo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marzia Lazzerini, MD
Role: STUDY_DIRECTOR
IRCCS materno infantile Burlo Garofolo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ospedale San Polo Monfalcone
Monfalcone, Gorizia, Italy
Ospedale di S. Antonio
San Daniele, Udine, Italy
Ospedale di San Vito al Tagliamento
San Vito al Tagliamento, Udine, Italy
Ospedale di S. Antonio Abate
Tolmezzo, Udine, Italy
Casa di Cura Policlinico San Giorgio
Pordenone, , Italy
IRCCS Burlo Garofolo
Trieste, , Italy
Ospedale di Palmanova
Udine, , Italy
Presidio Ospedaliero Universitario Santa Maria della Misericordia
Udine, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Role: primary
Role: primary
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC 16/22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.